Founded by Johnson&Johnson in 1999, Mediliant manufactures orthopedic implants for laboratories (OEMs), mainly in traumatology, extremity and spine. The company assists its clients all stages of manufacturing and has an integrated offer from prototyping to sterile packaging of products. Based in Switzerland, the production meets the most stringent regulatory requirements (CE marking, FDA, ANVISA, etc.).
Investment date: 2019
Investment type: MBO
